Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Cullinan Therapeutics (CGEM) Leases (2022 - 2023)

Cullinan Therapeutics has reported Leases over the past 2 years, most recently at $2.9 million for Q3 2023.

  • Quarterly results put Leases at $2.9 million for Q3 2023, down 34.94% from a year ago — trailing twelve months through Sep 2023 was $2.9 million (down 34.94% YoY), and the annual figure for FY2022 was $4.1 million, changed.
  • Leases for Q3 2023 was $2.9 million at Cullinan Therapeutics, down from $3.5 million in the prior quarter.
  • Over the last five years, Leases for CGEM hit a ceiling of $4.5 million in Q3 2022 and a floor of $1.1 million in Q2 2022.